Gsa Capital Partners LLP Adma Biologics, Inc. Transaction History

Gsa Capital Partners LLP

  • $1.32 Billion
  • Q3 2024

A detailed history of Gsa Capital Partners LLP transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 35,313 shares of ADMA stock, worth $614,799. This represents 0.05% of its overall portfolio holdings.

Number of Shares
35,313
Previous 144,358 75.54%
Holding current value
$614,799
Previous $1.61 Million 56.26%
% of portfolio
0.05%
Previous 0.11%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
SELL
$11.21 - $20.03 $1.22 Million - $2.18 Million
-109,045 Reduced 75.54%
35,313 $706,000
Q2 2024

Aug 15, 2024
BUY
$5.98 - $11.18 $56,385 - $105,416
9,429 Added 6.99%
144,358 $1.61 Million
Q1 2024

May 03, 2024
BUY
$4.4 - $6.74 $520,146 - $796,769
118,215 Added 707.28%
134,929 $890,000
Q4 2023

Feb 16, 2024
SELL
$3.08 - $4.52 $694,755 - $1.02 Million
-225,570 Reduced 93.1%
16,714 $75,000
Q3 2023

Nov 15, 2023
BUY
$3.47 - $4.61 $392,748 - $521,778
113,184 Added 87.67%
242,284 $867,000
Q2 2023

Aug 14, 2023
BUY
$3.12 - $4.22 $192,273 - $260,061
61,626 Added 91.33%
129,100 $476,000
Q1 2023

May 12, 2023
SELL
$3.01 - $3.87 $303,853 - $390,668
-100,948 Reduced 59.94%
67,474 $223,000
Q4 2022

Feb 13, 2023
BUY
$2.47 - $3.88 $416,002 - $653,477
168,422 New
168,422 $653,000
Q1 2022

May 11, 2022
SELL
$1.28 - $1.83 $123,619 - $176,737
-96,578 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$1.09 - $1.66 $554,438 - $844,373
-508,659 Reduced 84.04%
96,578 $136,000
Q3 2021

Nov 12, 2021
SELL
$1.13 - $1.65 $288,911 - $421,862
-255,674 Reduced 29.7%
605,237 $684,000
Q2 2021

Aug 05, 2021
BUY
$1.51 - $2.07 $470,043 - $644,364
311,287 Added 56.64%
860,911 $1.38 Million
Q1 2021

May 10, 2021
BUY
$1.67 - $2.95 $371,695 - $656,587
222,572 Added 68.05%
549,624 $967,000
Q4 2020

Feb 03, 2021
BUY
$1.8 - $2.56 $168,528 - $239,685
93,627 Added 40.11%
327,052 $638,000
Q3 2020

Nov 06, 2020
BUY
$2.04 - $3.74 $476,187 - $873,009
233,425 New
233,425 $558,000
Q2 2020

Aug 11, 2020
SELL
$2.42 - $3.29 $293,444 - $398,938
-121,258 Closed
0 $0
Q1 2020

May 12, 2020
BUY
$1.5 - $4.59 $112,761 - $345,048
75,174 Added 163.12%
121,258 $349,000
Q4 2019

Feb 12, 2020
BUY
$3.89 - $5.15 $179,266 - $237,332
46,084 New
46,084 $184,000

Others Institutions Holding ADMA

# of Institutions
319
Shares Held
184M
Call Options Held
917K
Put Options Held
91.6K
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.42B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email